The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...
The FDA granted fast track designation for CTx001, an investigational gene therapy candidate for geographic atrophy secondary ...
Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...
Akebia Therapeutics is refocusing on Vafseo for dialysis patients, discontinuing expansion to non-dialysis, which has reset ...
Advancing investigational pre-clinical research of APL-9099 3, a potential one-time neonatal Fc receptor (FcRn) treatment ...
US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...
In turn, the company—which is broadly seeking to develop inflammatory drugs targeting the complement system—anticipates ...
On November 2, 2025, the research group led by Dr. Zeng Ling from Army Medical University systematically elucidated the molecular mechanisms, ...
Discover Oregon restaurants locals love that most travelers drive past, serving unforgettable food in unassuming roadside ...
The new MiCO map helps scientists, conservationists, and policymakers quickly see global migration patterns for 109 species.
Central Avenue in St. Pete holds plenty of surprises, and The Burg Bar & Grill at 1752 Central Ave, St. Petersburg, FL 33712 ...
Taylor Franck has returned to the Mustangs after a seven-game absence (leg injury). She hasn't exactly limped back.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback